
The CMS Final Decision Memorandum discussed the Watch-PAT and the clinical evidence supporting its efficacy in very positive detail. Of particular note is CMS’s response to comments that asserted that the Watch-PAT is a useful diagnostic tool and should not be required to provide additional data under Coverage with Evidence Development... Itamar Medical's Press Release -